- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06258044
The Application Value of Deep Learning-Based Nomograms in Benign-Malignant Discrimination of TI-RADS Category 4 Thyroid Nodules
This retrospective study focuses on benign and malignant classification of thyroid nodules using deep learning techniques and evaluates the value of deep learning based nomograms in the classification of TI-RADS category 4 thyroid nodules to improve the accuracy of benign and malignant identification of TI-RADS category 4 thyroid nodules.
Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Shandong
-
Jinan, Shandong, China
- QianfoshanH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Ultrasound-confirmed diagnosis of thyroid nodules that are classified as TI-RADS category 4.
- Availability of pathological results.
Exclusion Criteria:
- Lack of pathological diagnosis.
- History of thyroid surgery or other treatments.
- Poor quality of ultrasound images of thyroid nodules.
- Incomplete clinical and imaging data of the patient.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
maligant
Thyroid nodules with surgical or puncture biopsy-confirmed pathological findings of malignancy in the TI-RADS4 category
|
|
benign
Thyroid nodules with surgical or puncture biopsy-confirmed pathological findings of benign TI-RADS4 category
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
deep learning prediction model(YOLOv3) and the model evaluation
Time Frame: Immediately evaluated after the prediction model was built
|
Based on the characteristics of benign and malignant thyroid nodules, the dataset was divided into a training set and a test set using the cross-validation method, and the YOLOv3 model was trained using data from the training set, and the performance of the model was evaluated using data from the test set.The model is evaluated using a number of metrics such as: precision-recall curve, effective classification precision, confusion matrix and area under the curve.
|
Immediately evaluated after the prediction model was built
|
|
nomogram prediction and assessment
Time Frame: Immediately evaluated after the nomogram was built
|
Factoring clinical features, ultrasound grading and model predictions to map nomograms using R language.Evaluation of the nomogram using various metrics, including subject operating characteristic curves, calibration curves and decision curve analysis
|
Immediately evaluated after the nomogram was built
|
|
Selection of clinical features and assessment
Time Frame: After the dataset is collected and pathology results are obtained, the statistical results obtained are analyzed for clinical factors, averaging about 1 year.
|
The researchers selected patients with TI-RADS category 4 thyroid nodules within 1 year to comprise the dataset.
The researchers analyzed the clinical factors in the dataset and analyzed the significance of these clinical factors on the statistical results and clinical characteristics using the Wilcoxon two-sample rank sum test or chi-square test.
|
After the dataset is collected and pathology results are obtained, the statistical results obtained are analyzed for clinical factors, averaging about 1 year.
|
|
Impact and assessment of ultrasound grading
Time Frame: The graded results of the ultrasound examination were analyzed after the data set collection was completed, the ultrasound examination was completed and the final pathology results were obtained, on average about 1 year.
|
The researchers selected patients with TI-RADS category 4 thyroid nodules within 1 year to comprise the dataset.
The researchers analyzed the results of grading TI-RADS category 4 nodules in this dataset and determined the significance of ultrasound grading on the statistical results using the chi-square test.
|
The graded results of the ultrasound examination were analyzed after the data set collection was completed, the ultrasound examination was completed and the final pathology results were obtained, on average about 1 year.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YXLL-KY-2023(133)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Nodule
-
Tseung Kwan O Hospital, Hong KongRecruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid NoduleHong Kong
-
Brigham and Women's HospitalHarvard School of Public Health (HSPH); Agency for Healthcare Research and...Active, not recruitingThyroid Cancer | Thyroid Nodule (Benign) | Thyroid Nodule (Diagnosis)United States
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; AZ Sint-Jan AVRecruitingBenign Thyroid NoduleBelgium
-
Suez UniversityNot yet recruiting
-
Minia UniversityCompletedBenign Thyroid NoduleEgypt
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University... and other collaboratorsTerminatedRadiofrequency Ablation | Thyroid Nodule, Toxic or With Hyperthyroidism | Autonomous Thyroid Function | Thyroid Nodule; Hyperthyroidism | Iodine Hyperthyroidism | Iodine Adverse ReactionNetherlands
-
Imperial College LondonActive, not recruitingThyroid Cancer | Nodule Solitary ThyroidUnited Kingdom
-
Aarhus University HospitalOdense University Hospital; University of AarhusActive, not recruitingThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
Insel Gruppe AG, University Hospital BernRecruitingThyroid Nodule (Diagnosis)Switzerland
-
Pulse Biosciences, Inc.CompletedThyroid Nodule (Benign)Italy